Transplantation, AutologousTransplantation, HomologousKidney TransplantationGraft SurvivalHematopoietic Stem Cell TransplantationLiver TransplantationBone Marrow TransplantationGraft RejectionImmunosuppressive AgentsTransplantation ConditioningStem Cell TransplantationTime FactorsHeart TransplantationLung TransplantationMultiple MyelomaCell TransplantationTreatment OutcomePeripheral Blood Stem Cell TransplantationMelphalanOrgan TransplantationHematopoietic Stem Cell MobilizationGraft vs Host DiseaseCombined Modality TherapyPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsRecurrenceTransplantationTransplantation ImmunologyLymphoma, Non-HodgkinAntigens, CD34Salvage TherapyWhole-Body IrradiationTransplantation ChimeraBone Marrow PurgingRetrospective StudiesCarmustineCyclophosphamideRemission InductionHematopoietic Stem CellsAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactorSurvival AnalysisLeukapheresisHematologic NeoplasmsTransplantation, IsogeneicBusulfanDisease-Free SurvivalSurvival RateLiving DonorsTransplantation, HeterotopicCord Blood Stem Cell TransplantationFollow-Up StudiesHeart-Lung TransplantationEtoposideHodgkin DiseaseTissue and Organ ProcurementTransplantation ToleranceMyeloablative AgonistsCytarabineBlood Transfusion, AutologousImmunosuppressionGraft vs Tumor EffectHistocompatibility TestingLiver FailureFetal Tissue TransplantationPostoperative ComplicationsSkin TransplantationBone MarrowPrognosisMesenchymal Stem Cell TransplantationLeukemiaTransplantation, HeterologousThalidomideWaiting ListsTissue TransplantationFeasibility StudiesHematopoiesisCells, CulturedHistocompatibilityKanamycin KinaseBone Marrow CellsCorneal TransplantationVincristineBlood Component RemovalLeukemia, Myeloid, AcuteLymphomaNeoplasm, ResidualStem CellsTacrolimusCyclosporineCell SeparationPrednisoneProspective StudiesMyelodysplastic SyndromesGenetic TherapyCadaverColony-Forming Units AssayIdarubicinAntineoplastic Agents, Alkylating